Ethyl 4-hydroxy-6-(trifluoromethyl)nicotinate, 95.0%, 1g

2,6-Difluoro-4-methoxyphenylboronic acid, 95.0%, 1g

3-[bis(2-methoxyethyl)amino]propanoic acid, 95.0%, 2g

Reagent reservoirs for 8/12 channel pipettes, Non sterile, 50 pieces, 50 pieces

[(4',4'-ETHYLENEDIOXY)CYCLOHEXYL]METHYL METHANESULFONATE, 95.0%, 1g

(1-TOSYL-1H-INDOL-3-YL)METHANOL, 95.0%, 500mg

5-Chloro-2-methylnicotinaldehyde, 95.0%, 250mg

(2-BROMOETHOXY)CYCLOHEXANE, 95%, 1g

4-Chloro-6-methoxymethyl-2-phenylpyrimidine, 97%, 5g

2-Nitro-5-(phenylthio)aniline, 97.0%, 1g

Butanedioic acid, 2-hydroxy-, (2S)-, compd. with (3S,4S)-1,1-dimethylethyl 3-hydroxy-4-(methylamino)-1-pyrrolidinecarboxylate (1:1), 98%, 100mg

3-(Methoxymethyl)-3-methylpiperidine hydrochloride, 97%, 1g

(E)-N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-(N,N'-diethylcarbamimidoyl)-L-lysine hydrochloride, 98%, 10g